NASDAQ:TECH

Bio-techne Stock Insider Trading

Healthcare > Biotechnology

Buy TECH

*Your capital is at risk

$50.85

+1.08 (+2.17%)

At Close: Jun 03, 2026

Bio-Techne Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.84. In total, the insiders bought 1M and sold 279.65K TECH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	30.84
● Buy	1M shares
● Sell	279.65K shares
78% Buy Activity Weak Positive Correlation
Buy Signal Medium Confidence Mar 02, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 30.84. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 25, 2025 Buy	Common Stock M-Exempt	Baumgartner Robert V Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Sell	Common Stock S-Sale	Baumgartner Robert V Director	Director	17 040 Value: $957.8K
Aug 25, 2025 Buy	Stock Options (Right to Buy) M-Exempt	Baumgartner Robert V Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Buy	Stock Options (Right to Buy) M-Exempt	Baumgartner Robert V Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Sell	Common Stock S-Sale	Baumgartner Robert V Director	Director	17 040 Value: $957.8K
Aug 25, 2025 Buy	Common Stock M-Exempt	Baumgartner Robert V Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Buy	Stock Options (Right to Buy) M-Exempt	Nusse Roeland Director	Director	17 040 Value: $372.2K
Aug 25, 2025 Sell	Common Stock S-Sale	Nusse Roeland Director	Director	17 040 Value: $960.4K
Aug 25, 2025 Buy	Common Stock M-Exempt	Nusse Roeland Director	Director	17 040 Value: $372.2K
Aug 15, 2025 Buy	Common Stock M-Exempt	Hippel James CFO	C-Suite Officer	4 010 Value: $214.9K
Aug 15, 2025 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	1 926 Value: $103.2K
Aug 15, 2025 Buy	Stock Options (Right to Buy) A-Award	Hippel James CFO	C-Suite Officer	37 632 Value: $2.02M
Aug 15, 2025 Buy	Performance Restricted Stock Units A-Award	Hippel James CFO	C-Suite Officer	29 420 Value: $1.58M
Aug 15, 2025 Buy	Restricted Stock Units A-Award	Hippel James CFO	C-Suite Officer	14 710 Value: $788.5K
Aug 15, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	4 010 Value: $214.9K
Aug 15, 2025 Buy	Restricted Stock Units M-Exempt	Geist William President, Protein Sciences	CEO / President	2 623 Value: $140.6K
Aug 15, 2025 Buy	Restricted Stock Units A-Award	Geist William President, Protein Sciences	CEO / President	9 678 Value: $518.7K
Aug 15, 2025 Sell	Common Stock F-InKind	Herr Amy E. Director	Director	101 Value: $5K
Aug 15, 2025 Buy	Common Stock M-Exempt	Herr Amy E. Director	Director	279 Value: $15.0K
Aug 15, 2025 Buy	Stock Option (Right to Buy) A-Award	Herr Amy E. Director	Director	2 735 Value: $146.6K
Aug 15, 2025 Buy	Restricted Stock Units M-Exempt	Hippel James CFO	C-Suite Officer	4 010 Value: $214.9K
Aug 15, 2025 Buy	Restricted Stock Units A-Award	Hippel James CFO	C-Suite Officer	14 710 Value: $788.5K
Aug 15, 2025 Buy	Performance Restricted Stock Units A-Award	Hippel James CFO	C-Suite Officer	29 420 Value: $1.58M
Aug 15, 2025 Buy	Stock Options (Right to Buy) A-Award	Hippel James CFO	C-Suite Officer	37 632 Value: $2.02M
Aug 15, 2025 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	1 926 Value: $103.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIO-TECHNE CORP

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, s...

Read Full Profile Here